Cargando…
Apoptin enhances the oncolytic properties of vaccinia virus and modifies mechanisms of tumor regression
A recombinant vaccinia virus VVdGF-ApoS24/2 expressing apoptin selectively kills human cancer cells in vitro [Kochneva et al., 2013]. We compared the oncolytic activity of this recombinant with that of the parental strain L-IVP using a model of human A431 carcinoma xenografts in nude mice. Single in...
Autores principales: | Kochneva, Galina, Zonov, Evgeniy, Grazhdantseva, Antonina, Yunusova, Anastasiya, Sibolobova, Galina, Popov, Evgeniy, Taranov, Oleg, Netesov, Sergei, Chumakov, Peter, Ryabchikova, Elena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4294355/ https://www.ncbi.nlm.nih.gov/pubmed/25358248 |
Ejemplares similares
-
Features of the Antitumor Effect of Vaccinia Virus Lister Strain
por: Zonov, Evgeniy, et al.
Publicado: (2016) -
Engineering of double recombinant vaccinia virus with enhanced oncolytic potential for solid tumor virotherapy
por: Kochneva, Galina, et al.
Publicado: (2016) -
Genotypic variability and risk factors of hepatitis B virus in Western Siberia
por: Bayandin, Roman, et al.
Publicado: (2011) -
Directed evolution as a tool for the selection of oncolytic RNA viruses with desired phenotypes
por: Zainutdinov, Sergei S, et al.
Publicado: (2019) -
Recombinant Vaccinia Viruses Coding Transgenes of Apoptosis-Inducing Proteins Enhance Apoptosis But Not Immunogenicity of Infected Tumor Cells
por: Koval, Olga, et al.
Publicado: (2017)